Reference
Paepegaey A-C, et al. Polyendocrinopathy resulting from pembrolizumab in a patient with a Malignant Melanoma. Journal of the Endocrine Society 1: 646-649, No. 6, Jun 2017. Available from: URL: http://doi.org/10.1210/js.2017-00170 -France
Rights and permissions
About this article
Cite this article
Pembrolizumab. Reactions Weekly 1726, 272 (2018). https://doi.org/10.1007/s40278-018-53911-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-53911-x